Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Associated Press - December 3, 2005
Dr. Helene Gayle will oversee an annual budget of $624 million and a staff of 12,000 in 70 countries.
In her five years as director of HIV, tuberculosis and reproductive health at the Gates Foundation, Gayle led a $200 million program to keep AIDS from overwhelming India, helped draft a plan to find an HIV vaccine and ramped up TB prevention, treatment and research. Projects in her $1.5 billion portfolio touch a range of people from truck drivers in Botswana to sex workers in China.
Patty Stonesifer, foundation co-chairwoman and president, said she would miss Gayle's leadership, intelligence and humor. "We are grateful for her many contributions," Stonesifer said.
Gayle's departure from the world's largest philanthropy leaves two top jobs there unfilled.
In September, Dr. Richard Klausner resigned as the foundation's executive director of global health. Klausner is under congressional investigation for alleged conflict of interest in a $40 million contract awarded to Harvard University when he was director of the National Cancer Institute.
Gayle, 50, was rumored to be on the short list to replace him, but said that taking the helm of CARE was irresistible.
Gayle left the U.S. Centers for Disease Control and Prevention in 2001 to lead the Gates Foundation's AIDS programs.
She said she would be leaving the foundation with a "jumble of emotions," but called the CARE job an opportunity to get even more involved in the issues she cares about most.
"I went into medicine and public health to work on issues of social justice and inequity," Gayle said, adding that CARE operates even more directly than the Gates Foundation on the front lines of global poverty and social justice.
As CEO of CARE, Gayle will replace Peter Bell, 65, who is leaving after 10 years.
At the Gates Foundation, Dr. Nicholas Hellmann will be interim director of HIV, tuberculosis and reproductive health.
051203
AP051210
Copyright © 2005 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .